CLOX 📈 Series Portfolios Trust - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • • Ultrashort Bond
CLOX: Collateralized, Loan, Obligations, Rated, Securities
The fund is an actively managed exchange-traded fund ('ETF') that pursues its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings made for investment purposes) in collateralized loan obligations ('CLOs') that are rated, at the time of purchase, AAA or an equivalent rating by a nationally recognized statistical rating organization ('NRSRO') (or, if unrated, securities deemed by the adviser to be of comparable quality). The fund is non-diversified.
Additional Sources for CLOX ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CLOX ETF Overview
| Market Cap in USD | 102m |
| Category | Ultrashort Bond |
| TER | 0.21% |
| IPO / Inception | 2023-07-18 |
CLOX ETF Ratings
| Growth 5y | 61.1% |
| Fundamental | - |
| Dividend | 59.2% |
| Rel. Strength Industry | 197 |
| Analysts | - |
| Fair Price Momentum | 25.88 USD |
| Fair Price DCF | - |
CLOX Dividends
| Dividend Yield 12m | 5.99% |
| Yield on Cost 5y | 6.67% |
| Annual Growth 5y | 40.60% |
| Payout Consistency | 100.0% |
CLOX Growth Ratios
| Growth Correlation 3m | 97.1% |
| Growth Correlation 12m | 99.9% |
| Growth Correlation 5y | 99.9% |
| CAGR 5y | 7.72% |
| CAGR/Mean DD 5y | 152.97 |
| Sharpe Ratio 12m | 1.64 |
| Alpha | 2.11 |
| Beta | 0.03 |
| Volatility | 1.87% |
| Current Volume | 25.4k |
| Average Volume 20d | 55.8k |
What is the price of CLOX stocks?
As of December 27, 2024, the stock is trading at USD 25.60 with a total of 25,400 shares traded.
Over the past week, the price has changed by +0.04%, over one month by +0.77%, over three months by +1.64% and over the past year by +7.17%.
As of December 27, 2024, the stock is trading at USD 25.60 with a total of 25,400 shares traded.
Over the past week, the price has changed by +0.04%, over one month by +0.77%, over three months by +1.64% and over the past year by +7.17%.
Is Series Portfolios Trust a good stock to buy?
Yes. Based on ValueRay Analyses, Series Portfolios Trust (NYSE ARCA:CLOX) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 61.08 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLOX as of December 2024 is 25.88. This means that CLOX is currently overvalued and has a potential downside of 1.09%.
Yes. Based on ValueRay Analyses, Series Portfolios Trust (NYSE ARCA:CLOX) is currently (December 2024) a good stock to buy. It has a ValueRay Growth Rating of 61.08 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CLOX as of December 2024 is 25.88. This means that CLOX is currently overvalued and has a potential downside of 1.09%.
Is CLOX a buy, sell or hold?
Series Portfolios Trust has no consensus analysts rating.
Series Portfolios Trust has no consensus analysts rating.
What are the forecast for CLOX stock price target?
According to ValueRays Forecast Model, CLOX Series Portfolios Trust will be worth about 28 in December 2025. The stock is currently trading at 25.60. This means that the stock has a potential upside of +9.22%.
According to ValueRays Forecast Model, CLOX Series Portfolios Trust will be worth about 28 in December 2025. The stock is currently trading at 25.60. This means that the stock has a potential upside of +9.22%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 28 | 9.2% |